Changes in eGFR, CKD stage, proteinuria, and blood pressure.Ki, Heon NamJeong, Hae KieMi Jung, LeeTaeIk, ChangEa, Wha KangDong Wook, KimBeom, Jin LimJung, Tak ParkYoung, Eun KwonYung, Ly Kim
估算的肾小球滤过率(eGFR)是界定慢性肾脏病及其分期的基本指标,对于提高对慢性肾脏病的认识,筛查高危人群,指导临床慢病管理和肾病研究具有重要作用。 但与年龄相关的肾功能下降(生理器官衰老)与进展性 CKD 对健康具有不同的影响。随着全球 65 岁或 65 岁以上人群的持续增长,对老年 CKD 过度诊断的担忧日益增加。现有...
由此研究可推出eGFR斜率的变化可能导致糖尿病患者罹患CKD的风险增加,且ESKD的发生风险亦会增加,这为未来在临床对于患者危险分层的预测价值提供了重要参考指标,eGFR斜率有望成为更好的该类患者分层指标,然而尚无关于eGFR斜率的中国人群相关大型...
但与年龄相关的肾功能下降(生理器官衰老)与进展性 CKD 对健康具有不同的影响。随着全球 65 岁或 65 岁以上人群的持续增长,对老年 CKD 过度诊断的担忧日益增加。现有数据显示,CKD 患病率的增加与终末期肾病发病率的成比例增加无关,而且在特定的...
Background and objectives The association of individual BP components with changes in eGFR in patients with late-stage CKD is unknown. The objectives of our study were to examine the associations of systolic BP, diastolic BP, and pulse pressure with continuous temporal changes in eGFR and an eGFR...
non—dialysiSCKD(stage卜5)wereselectedinourhospitalfromOctober 2008toOctober2009.2.Clinicaldatawere recorded,includingSCX,age, height,weight,smokingStatus,bloodpressure,fastingglUcose, high—densitylipoproteincholesterol(HDL—C),low—density1ipoprotein
As reported in numerous studies, uric acid is related to renal function in CKD patients, and most patients typically seek medical attention only at the CKD stage. However, there are only a few reports on whether elevated uric acid levels are associated with a mild decrease in the eGFR in ...
An increased rate of hip fractures has been reported in patients with end-stage renal disease, but the effect of less severe renal dysfunction on fracture ... Ensrud,E Kristine - 《Archives of Internal Medicine》 被引量: 323发表: 2007年 Comparison of Fracture Risk Prediction among Individuals ...
Statistical analysis revealed a meaningful difference in the variables of gender, duration of use, chewing time, tobacco juice swallowing, and clinical stage of Oral Submucous Fibrosis (OSMF).A significant cause for alarm is the discovery that nearly 70% of the subjects involved in the OSMF study...
CKD has a prevalence of 15% and affects 30 million people in the US4,5. In addition to the risk of progressing to end-stage-renal disease (ESRD), CKD is associated with significant cardiovascular morbidity and mortality6,7. Patients with an eGFR of <15 ml/min/1.73 m2, for ...